
The U.S. Food and Drug Administration on Tuesday approved the country’s first continuous glucose monitor for type 2 diabetes. The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2 diabetes but do not take insulin, according to the agency. Also known… read on > read on >